Last 12 months
Inside the activity.
13 purchase rows · 7 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 4 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 3 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 5 | 3 |
| Jun 2026 | 1 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 06, 2022 Filed Jun 30, 2023 20:18 UTC |
Crowley Thomas Aloysius Jr.Director
|
SaleCommon Stock | 3,500 | $2.29 | $8,001.00 |
DisclosureSEC source: 0001209191-23-040313 · doc4.xml · nonDerivative · entry 1 Crowley Thomas Aloysius Jr. · CIK 0001706753 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,401 F1 · date: Due to oversight, these reported sale transactions were not reported timely and are being reported at this time. F2 · price: Represents average sales price for the reported transaction. The reporting person undertakes to provide Myomo, Inc., any security holder of Myomo, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the average price set forth herein. Read SEC document |
| June 03, 2022 Filed Jun 3, 2022 23:20 UTC |
Kovelman HarryChief Medical Officer
|
Tax withholdingCommon Stock | 138 | $2.31 | $318.78 |
DisclosureSEC source: 0001209191-22-034354 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,954 F1 · shares: Represents shares sold on June 3, 2022 solely to pay income taxes resulting from vesting of restricted stock units on June 2, 2022. Read SEC document |
| May 24, 2022 Filed May 24, 2022 22:15 UTC |
Kovelman HarryChief Medical Officer
|
Tax withholdingCommon Stock | 2,849 | $2.06 | $5,868.94 |
DisclosureSEC source: 0001209191-22-031711 · doc4.xml · nonDerivative · entry 2 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,092 F2 · shares: Represents shares sold on May 24, 2022 solely to pay income taxes resulting from vesting of restricted stock units on May 20, 2022. Read SEC document |
| May 24, 2022 Filed May 24, 2022 21:54 UTC |
HENRY DAVID AChief Financial Officer
|
Tax withholdingCommon Stock | 3,394 | $2.06 | $6,991.64 |
DisclosureSEC source: 0001209191-22-031703 · doc4.xml · nonDerivative · entry 2 HENRY DAVID A · CIK 0001195842 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,521 F2 · shares: Represents shares sold on May 24, 2022 solely to pay income taxes resulting from vesting of restricted stock units on May 20, 2022. Read SEC document |
| May 20, 2022 Filed May 24, 2022 20:59 UTC |
GUDONIS PAUL RDirector · Chief Executive Officer
|
GrantCommon Stock | 8,302 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-031640 · doc4.xml · nonDerivative · entry 1 GUDONIS PAUL R · CIK 0001015994 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,320 F1 · shares: Represents grant of Restricted Stock Units under the Issuer's 2018 Stock Option Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units vested in full on the date of grant. Read SEC document |
| May 20, 2022 Filed May 24, 2022 22:15 UTC |
Kovelman HarryChief Medical Officer
|
GrantCommon Stock | 6,987 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-031711 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,941 F1 · shares: Represents grant of Restricted Stock Units under the Issuer's 2018 Stock Option Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units vested in full on the date of grant. Read SEC document |
| May 20, 2022 Filed May 24, 2022 22:16 UTC |
Mitchell MicahChief Commerical Officer
|
GrantCommon Stock | 7,424 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-031714 · doc4.xml · nonDerivative · entry 1 Mitchell Micah · CIK 0001746072 · Chief Commerical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,277 F1 · shares: Represents grant of Restricted Stock Units under the Issuer's 2018 Stock Option Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units vested in full on the date of grant. Read SEC document |
| May 20, 2022 Filed May 24, 2022 21:54 UTC |
HENRY DAVID AChief Financial Officer
|
GrantCommon Stock | 8,297 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-031703 · doc4.xml · nonDerivative · entry 1 HENRY DAVID A · CIK 0001195842 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,915 F1 · shares: Represents grant of Restricted Stock Units under the Issuer's 2018 Stock Option Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units vested in full on the date of grant. Read SEC document |
| May 03, 2022 Filed May 3, 2022 20:27 UTC |
Kovelman HarryChief Medical Officer
|
Tax withholdingCommon Stock | 134 | $3.03 | $406.02 |
DisclosureSEC source: 0001209191-22-026720 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,954 F1 · shares: Represents shares sold on May 3, 2022 solely to pay income taxes resulting from vesting of restricted stock units on May 2, 2022. Read SEC document |
| April 04, 2022 Filed Apr 4, 2022 22:44 UTC |
Kovelman HarryChief Medical Officer
|
Tax withholdingCommon Stock | 134 | $4.01 | $537.34 |
DisclosureSEC source: 0001209191-22-022670 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,088 F1 · shares: Represents shares sold on April 4, 2022 solely to pay income taxes resulting from vesting of restricted stock units on April 2, 2022. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 12:46 UTC |
GUDONIS PAUL RDirector · Chief Executive Officer
|
PurchaseCommon Stock | 5,000 | $4.22 | $21,085.00 |
DisclosureSEC source: 0001209191-22-019070 · doc4.xml · nonDerivative · entry 1 GUDONIS PAUL R · CIK 0001015994 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,018 F1 · shares: Represents a open market purchase by the reporting person F2 · price: Represents average purchase price. Shares were purchased at prices ranging from $4.185 - $4.23 per share Read SEC document |
| March 11, 2022 Filed Mar 12, 2022 00:55 UTC |
GUDONIS PAUL RDirector · Chief Executive Officer
|
PurchaseCommon Stock | 5,000 | $4.63 | $23,145.50 |
DisclosureSEC source: 0001209191-22-018311 · doc4.xml · nonDerivative · entry 1 GUDONIS PAUL R · CIK 0001015994 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,018 F1 · shares: Represents a open market purchase by the reporting person F2 · price: Represents average purchase price. Shares were purchased at prices ranging from $4.40 - $4.7158 per share Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 00:52 UTC |
Kovelman HarryChief Medical Officer
|
Tax withholdingCommon Stock | 131 | $7.22 | $945.82 |
DisclosureSEC source: 0001209191-22-017332 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,222 F1 · shares: Represents shares sold on March 7, 2022 solely to pay income taxes resulting from vesting of restricted stock units on March 2, 2022. Read SEC document |
| February 03, 2022 Filed Feb 4, 2022 23:15 UTC |
Kovelman HarryChief Medical Officer
|
Tax withholdingCommon Stock | 132 | $7.60 | $1,003.20 |
DisclosureSEC source: 0001209191-22-007308 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,353 F1 · shares: Represents shares sold on February 3, 2022 solely to pay income taxes resulting from vesting of restricted stock units on February 2, 2022. Read SEC document |
| January 03, 2022 Filed Jan 4, 2022 23:17 UTC |
Kovelman HarryChief Medical Officer
|
Tax withholdingCommon Stock | 125 | $7.22 | $902.50 |
DisclosureSEC source: 0001209191-22-001143 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,485 F1 · shares: Represents shares sold on January 3, 2022 solely to pay income taxes resulting from vesting of restricted stock units on January 2, 2022. Read SEC document |
| December 03, 2021 Filed Dec 3, 2021 22:36 UTC |
Kovelman HarryChief Medical Officer
|
Tax withholdingCommon Stock | 128 | $7.75 | $992.00 |
DisclosureSEC source: 0001209191-21-067936 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,610 F1 · shares: Represents shares sold on December 3, 2021 solely to pay income taxes resulting from vesting of restricted stock units on December 2, 2021. Read SEC document |
| November 16, 2021 Filed Nov 16, 2021 21:11 UTC |
HENRY DAVID AChief Financial Officer
|
PurchaseCommon Stock | 1,000 | $8.86 | $8,855.00 |
DisclosureSEC source: 0001209191-21-064745 · doc4.xml · nonDerivative · entry 1 HENRY DAVID A · CIK 0001195842 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,618 F1 · shares: Represents an open market purchase by the reporting person Read SEC document |
| November 12, 2021 Filed Nov 16, 2021 21:08 UTC |
GUDONIS PAUL RDirector · Chief Executive Officer
|
PurchaseCommon Stock | 1,000 | $9.86 | $9,857.70 |
DisclosureSEC source: 0001209191-21-064742 · doc4.xml · nonDerivative · entry 1 GUDONIS PAUL R · CIK 0001015994 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,018 F1 · shares: Represents a open market purchase by the reporting person Read SEC document |
| November 03, 2021 Filed Nov 4, 2021 21:20 UTC |
Kovelman HarryChief Medical Officer
|
Tax withholdingCommon Stock | 1,625 | $10.39 | $16,883.75 |
DisclosureSEC source: 0001209191-21-062972 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,738 F1 · shares: Represents shares sold on November 3, 2021 solely to pay income taxes resulting from vesting of restricted stock units on November 2, 2021. Read SEC document |
| November 02, 2021 Filed Nov 3, 2021 20:06 UTC |
Crowley Thomas Aloysius Jr.Director
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 208 | $0.00 Strike: $0.05 | $0.00 |
DisclosureSEC source: 0001209191-21-062671 · doc4.xml · derivative · entry 4 Crowley Thomas Aloysius Jr. · CIK 0001706753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 208 shares Expires 2024-03-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the exercise by Mr. Crowley of stock options granted January 23, 2013 and March 26, 2014. Read SEC document |
| November 02, 2021 Filed Nov 3, 2021 20:06 UTC |
Crowley Thomas Aloysius Jr.Director
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 211 | $0.00 Strike: $0.05 | $0.00 |
DisclosureSEC source: 0001209191-21-062671 · doc4.xml · derivative · entry 3 Crowley Thomas Aloysius Jr. · CIK 0001706753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 211 shares Expires 2023-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the exercise by Mr. Crowley of stock options granted January 23, 2013 and March 26, 2014. Read SEC document |
| November 02, 2021 Filed Nov 3, 2021 20:06 UTC |
Crowley Thomas Aloysius Jr.Director
|
Exercise / conversionCommon Stock | 208 | $0.05 | $9.98 |
DisclosureSEC source: 0001209191-21-062671 · doc4.xml · nonDerivative · entry 2 Crowley Thomas Aloysius Jr. · CIK 0001706753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,831 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the exercise by Mr. Crowley of stock options granted January 23, 2013 and March 26, 2014. Read SEC document |
| November 02, 2021 Filed Nov 3, 2021 20:06 UTC |
Crowley Thomas Aloysius Jr.Director
|
Exercise / conversionCommon Stock | 211 | $0.05 | $10.13 |
DisclosureSEC source: 0001209191-21-062671 · doc4.xml · nonDerivative · entry 1 Crowley Thomas Aloysius Jr. · CIK 0001706753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,042 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the exercise by Mr. Crowley of stock options granted January 23, 2013 and March 26, 2014. Read SEC document |
| July 21, 2021 Filed Jul 22, 2021 20:59 UTC |
Mitchell MicahChief Commerical Officer
|
SaleCommon Stock | 1,385 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-047782 · doc4.xml · nonDerivative · entry 2 Mitchell Micah · CIK 0001746072 · Chief Commerical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,853 F1 · kind: Shares were sold pursuant to a 10b5-1 trading plan entered into by the Reporting Person F3 · price: Shares were sold in multiple transactions at prices ranging from $9.01 to $9.15 per share Read SEC document |
| July 20, 2021 Filed Jul 22, 2021 20:59 UTC |
Mitchell MicahChief Commerical Officer
|
SaleCommon Stock | 5,745 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-047782 · doc4.xml · nonDerivative · entry 1 Mitchell Micah · CIK 0001746072 · Chief Commerical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,238 F1 · kind: Shares were sold pursuant to a 10b5-1 trading plan entered into by the Reporting Person F2 · price: Shares were sold in multiple transactions at prices ranging from $9.02 to $9.225 per share Read SEC document |
| June 11, 2021 Filed Jun 14, 2021 20:05 UTC |
Mitchell MicahChief Commerical Officer
|
Tax withholdingCommon Stock | 2,133 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-040219 · doc4.xml · nonDerivative · entry 1 Mitchell Micah · CIK 0001746072 · Chief Commerical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,982 F1 · shares: Represents shares sold on June 11, 2021 solely to pay income taxes resulting from vesting of restricted stock units on June 9, 2021. Shares were sold at prices ranging from $10.65 to $11.33 per share F1 · price: Represents shares sold on June 11, 2021 solely to pay income taxes resulting from vesting of restricted stock units on June 9, 2021. Shares were sold at prices ranging from $10.65 to $11.33 per share Read SEC document |
| June 11, 2021 Filed Jun 14, 2021 16:04 UTC |
CONNEIGHTON CLIFFChief Marketing Officer
|
Tax withholdingCommon Stock | 2,083 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-040217 · doc4.xml · nonDerivative · entry 1 CONNEIGHTON CLIFF · CIK 0001272037 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,738 F1 · shares: Represents shares sold on June 11, 2021 solely to pay income taxes resulting from vesting of restricted stock units on June 9, 2021. Shares were sold at prices ranging from $10.65 to $11.33 per share F1 · price: Represents shares sold on June 11, 2021 solely to pay income taxes resulting from vesting of restricted stock units on June 9, 2021. Shares were sold at prices ranging from $10.65 to $11.33 per share Read SEC document |
| June 11, 2021 Filed Jun 14, 2021 20:05 UTC |
HENRY DAVID AChief Financial Officer
|
Tax withholdingCommon Stock | 4,548 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-040218 · doc4.xml · nonDerivative · entry 1 HENRY DAVID A · CIK 0001195842 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,618 F1 · shares: Represents shares sold on June 11, 2021 solely to pay income taxes resulting from vesting of restricted stock units on June 9, 2021. Shares were sold at prices ranging from $10.65 to $11.33 per share F1 · price: Represents shares sold on June 11, 2021 solely to pay income taxes resulting from vesting of restricted stock units on June 9, 2021. Shares were sold at prices ranging from $10.65 to $11.33 per share Read SEC document |
| June 10, 2021 Filed Jun 11, 2021 20:44 UTC |
Mitchell MicahChief Commerical Officer
|
Tax withholdingCommon Stock | 154 | $11.51 | $1,772.54 |
DisclosureSEC source: 0001209191-21-039874 · doc4.xml · nonDerivative · entry 2 Mitchell Micah · CIK 0001746072 · Chief Commerical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,115 F2 · shares: Represents shares sold on June 10, 2021 solely to pay income taxes resulting from vesting of restricted stock units on June 5, 2021. Read SEC document |
| June 10, 2021 Filed Jun 11, 2021 16:40 UTC |
CONNEIGHTON CLIFFChief Marketing Officer
|
Tax withholdingCommon Stock | 208 | $11.51 | $2,394.08 |
DisclosureSEC source: 0001209191-21-039860 · doc4.xml · nonDerivative · entry 1 CONNEIGHTON CLIFF · CIK 0001272037 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,821 F1 · shares: Represents shares sold on June 10, 2020 solely to pay income taxes resulting from vesting of restricted stock units on June 5, 2021. Read SEC document |
| June 10, 2021 Filed Jun 11, 2021 20:06 UTC |
Crowley Thomas Aloysius Jr.Director
|
Exercise / conversionStock Options · Derivative | 208 | $0.05 Strike: $0.05 | $9.98 |
DisclosureSEC source: 0001209191-21-039806 · doc4.xml · derivative · entry 3 Crowley Thomas Aloysius Jr. · CIK 0001706753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 312 Underlying: Common Stock · 208 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.expiration_date: Represents the exercise of vested, exercisable stock options Read SEC document |
| June 10, 2021 Filed Jun 11, 2021 20:06 UTC |
Crowley Thomas Aloysius Jr.Director
|
Exercise / conversionStock Options · Derivative | 211 | $0.05 Strike: $0.05 | $10.13 |
DisclosureSEC source: 0001209191-21-039806 · doc4.xml · derivative · entry 2 Crowley Thomas Aloysius Jr. · CIK 0001706753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 520 Underlying: Common Stock · 211 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.expiration_date: Represents the exercise of vested, exercisable stock options Read SEC document |
| June 10, 2021 Filed Jun 11, 2021 20:06 UTC |
Crowley Thomas Aloysius Jr.Director
|
Exercise / conversionCommon Stock | 419 | $0.05 | $20.11 |
DisclosureSEC source: 0001209191-21-039806 · doc4.xml · nonDerivative · entry 1 Crowley Thomas Aloysius Jr. · CIK 0001706753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,042 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 09, 2021 Filed Jun 10, 2021 16:46 UTC |
Knapp Amy K.Director
|
GrantCommon Stock | 2,945 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-039510 · doc4.xml · nonDerivative · entry 1 Knapp Amy K. · CIK 0001707416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,623 F1 · shares: Represents grant of Restricted Stock Units (RSU's) under the Issuer's 2018 Stock Option and Incentive Plan. These RSU's shall vest in four quarterly installments beginning September 9, 2021 Read SEC document |
| June 09, 2021 Filed Jun 10, 2021 20:45 UTC |
KIRK THOMAS FDirector
|
GrantCommon Stock | 2,945 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-039507 · doc4.xml · nonDerivative · entry 1 KIRK THOMAS F · CIK 0001258258 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,180 F1 · shares: Represents grant of Restricted Stock Units (RSU's) under the Issuer's 2018 Stock Option and Incentive Plan. These RSU's shall vest in four quarterly installments beginning September 9, 2021 Read SEC document |
| June 09, 2021 Filed Jun 10, 2021 20:44 UTC |
Crowley Thomas Aloysius Jr.Director
|
GrantCommon Stock | 2,945 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-039506 · doc4.xml · nonDerivative · entry 1 Crowley Thomas Aloysius Jr. · CIK 0001706753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,623 F1 · shares: Represents grant of Restricted Stock Units (RSU's) under the Issuer's 2018 Stock Option and Incentive Plan. These RSU's shall vest in four quarterly installments beginning September 9, 2021 Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 20:06 UTC |
GUDONIS PAUL RChief Executive Officer
|
GrantRestricted Stock Units · Derivative | 40,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-039807 · doc4.xml · derivative · entry 2 GUDONIS PAUL R · CIK 0001015994 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires not disclosed F2 · shares: Represents performance-based grant of restricted stock units ("RSU's") under the Issuer's 2018 Stock Option and Incentive Plan. The RSU's shall vest three years from the grant date based on the relative stock price performance of Myomo's common stock compared to a peer group of six companies over the measurement period from June 10, 2021 to March 9, 2024. The RSU's reported herein represent the maximum number that could be earned if Myomo's stock price performance was in the 75th percentile or higher compared to the peer group. The minimum number of shares that could be issued is zero if Myomo's stock price performance was in the 25th percentile or less of the peer group. F2 · derivative.expiration_date: Represents performance-based grant of restricted stock units ("RSU's") under the Issuer's 2018 Stock Option and Incentive Plan. The RSU's shall vest three years from the grant date based on the relative stock price performance of Myomo's common stock compared to a peer group of six companies over the measurement period from June 10, 2021 to March 9, 2024. The RSU's reported herein represent the maximum number that could be earned if Myomo's stock price performance was in the 75th percentile or higher compared to the peer group. The minimum number of shares that could be issued is zero if Myomo's stock price performance was in the 25th percentile or less of the peer group. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 20:06 UTC |
GUDONIS PAUL RChief Executive Officer
|
GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-039807 · doc4.xml · nonDerivative · entry 1 GUDONIS PAUL R · CIK 0001015994 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,018 F1 · shares: Represents grant of Restricted Stock Units (RSU's) under the Issuer's 2018 Stock Option and Incentive Plan. These RSU's shall vest in three equal annual installments beginning on June 9, 2022. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 20:11 UTC |
Kovelman HarryChief Medical Officer
|
GrantRestricted Stock Units · Derivative | 8,200 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-039814 · doc4.xml · derivative · entry 2 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,200 Underlying: Common Stock · 8,200 shares Expires not disclosed F2 · shares: Represents performance-based grant of restricted stock units ("RSU's") under the Issuer's 2018 Stock Option and Incentive Plan. The RSU's shall vest three years from the grant date based on the relative stock price performance of Myomo's common stock compared to a peer group of six companies over the measurement period from June 10, 2021 to March 9, 2024. The RSU's reported herein represent the maximum number that could be earned if Myomo's stock price performance was in the 75th percentile or higher compared to the peer group. The minimum number of shares that could be issued is zero if Myomo's stock price performance was in the 25th percentile or less of the peer group. F2 · derivative.expiration_date: Represents performance-based grant of restricted stock units ("RSU's") under the Issuer's 2018 Stock Option and Incentive Plan. The RSU's shall vest three years from the grant date based on the relative stock price performance of Myomo's common stock compared to a peer group of six companies over the measurement period from June 10, 2021 to March 9, 2024. The RSU's reported herein represent the maximum number that could be earned if Myomo's stock price performance was in the 75th percentile or higher compared to the peer group. The minimum number of shares that could be issued is zero if Myomo's stock price performance was in the 25th percentile or less of the peer group. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 20:11 UTC |
Kovelman HarryChief Medical Officer
|
GrantCommon Stock | 4,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-039814 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,363 F1 · shares: Represents grant of Restricted Stock Units (RSU's) under the Issuer's 2018 Stock Option and Incentive Plan. These RSU's shall vest in three equal annual installments beginning on June 9, 2022. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 20:44 UTC |
Mitchell MicahChief Commerical Officer
|
GrantRestricted Stock Units · Derivative | 11,400 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-039874 · doc4.xml · derivative · entry 3 Mitchell Micah · CIK 0001746072 · Chief Commerical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,400 Underlying: Common Stock · 11,400 shares Expires not disclosed F3 · shares: Represents performance-based grant of restricted stock units ("RSU's") under the Issuer's 2018 Stock Option and Incentive Plan. The RSU's shall vest three years from the grant date based on the relative stock price performance of Myomo's common stock compared to a peer group of six companies over the measurement period from June 10, 2021 to March 9, 2024. The RSU's reported herein represent the maximum number that could be earned if Myomo's stock price performance was in the 75th percentile or higher compared to the peer group. The minimum number of shares that could be issued is zero if Myomo's stock price performance was in the 25th percentile or less of the peer group. F3 · derivative.expiration_date: Represents performance-based grant of restricted stock units ("RSU's") under the Issuer's 2018 Stock Option and Incentive Plan. The RSU's shall vest three years from the grant date based on the relative stock price performance of Myomo's common stock compared to a peer group of six companies over the measurement period from June 10, 2021 to March 9, 2024. The RSU's reported herein represent the maximum number that could be earned if Myomo's stock price performance was in the 75th percentile or higher compared to the peer group. The minimum number of shares that could be issued is zero if Myomo's stock price performance was in the 25th percentile or less of the peer group. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 20:44 UTC |
Mitchell MicahChief Commerical Officer
|
GrantCommon Stock | 5,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-039874 · doc4.xml · nonDerivative · entry 1 Mitchell Micah · CIK 0001746072 · Chief Commerical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,269 F1 · shares: Represents grant of Restricted Stock Units (RSU's) under the Issuer's, 2018 Stock Option and Incentive Plan. These RSU's shall vest in three equal annual installments beginning on June 9, 2022. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 20:40 UTC |
HENRY DAVID AChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 20,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-039863 · doc4.xml · derivative · entry 2 HENRY DAVID A · CIK 0001195842 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires not disclosed F2 · shares: Represents performance-based grant of restricted stock units ("RSU's") under the Issuer's 2018 Stock Option and Incentive Plan. The RSU's shall vest three years from the grant date based on the relative stock price performance of Myomo's common stock compared to a peer group of six companies over the measurement period from June 10, 2021 to March 9, 2024. The RSU's reported herein represent the maximum number that could be earned if Myomo's stock price performance was in the 75th percentile or higher compared to the peer group. The minimum number of shares that could be issued is zero if Myomo's stock price performance was in the 25th percentile or less of the peer group. F2 · derivative.expiration_date: Represents performance-based grant of restricted stock units ("RSU's") under the Issuer's 2018 Stock Option and Incentive Plan. The RSU's shall vest three years from the grant date based on the relative stock price performance of Myomo's common stock compared to a peer group of six companies over the measurement period from June 10, 2021 to March 9, 2024. The RSU's reported herein represent the maximum number that could be earned if Myomo's stock price performance was in the 75th percentile or higher compared to the peer group. The minimum number of shares that could be issued is zero if Myomo's stock price performance was in the 25th percentile or less of the peer group. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 20:40 UTC |
HENRY DAVID AChief Financial Officer
|
GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-039863 · doc4.xml · nonDerivative · entry 1 HENRY DAVID A · CIK 0001195842 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,166 F1 · shares: Represents grant of Restricted Stock Units (RSU's) under the Issuer's 2018 Stock Option and Incentive Plan. These RSU's shall vest in three equal annual installments beginning on June 9, 2022. Read SEC document |
| June 09, 2021 Filed Jun 21, 2021 23:22 UTC |
Morris Milton MayoDirector
|
GrantCommon Stock | 2,945 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-042264 · doc4.xml · nonDerivative · entry 1 Morris Milton Mayo · CIK 0001454309 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,945 F1 · shares: Represents grant of Restricted Stock Units (RSU's) under the Issuer's, 2018 Stock Option and Incentive Plan. These RSU's shall vest in four quarterly installments beginning September 9, 2021 Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 22:50 UTC |
GUDONIS PAUL RChief Executive Officer
|
GrantCommon Stock | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-041197 · doc4.xml · nonDerivative · entry 1 GUDONIS PAUL R · CIK 0001015994 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,133 F1 · shares: Represents grant of Restricted Stock Units (RSU's) under the Issuer's, 2018 Stock Option and Incentive Plan. These RSU's shall vest 50% on June 9, 2021, with the remainder in two equal annual installments beginning June 9. 2022. Read SEC document |
| July 01, 2020 Filed Jul 7, 2020 01:13 UTC |
Mitchell MicahChief Commerical Officer
|
GrantCommon Stock | 17,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-041402 · doc4.xml · nonDerivative · entry 1 Mitchell Micah · CIK 0001746072 · Chief Commerical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,569 F1 · shares: Represents grant of Restricted Stock Units (RSU's) under the Issuer's, 2018 Stock Option and Incentive Plan. These RSU's shall vest 50% on June 9, 2021, with the remainder in two equal annual installments beginning June 9. 2022. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 18:30 UTC |
Knapp Amy K.Director
|
GrantCommon Stock | 15,110 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-041166 · doc4.xml · nonDerivative · entry 1 Knapp Amy K. · CIK 0001707416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,678 F1 · shares: Represents grant of Restricted Stock Units (RSU's) under the Issuer's, 2018 Stock Option and Incentive Plan. These RSU's shall vest in four quarterly installments beginning September 9, 2020 Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 18:25 UTC |
CONNEIGHTON CLIFFChief Marketing Officer
|
GrantCommon Stock | 17,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-041155 · doc4.xml · nonDerivative · entry 1 CONNEIGHTON CLIFF · CIK 0001272037 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,029 F1 · shares: Represents grant of Restricted Stock Units (RSU's) under the Issuer's, 2018 Stock Option and Incentive Plan. These RSU's shall vest 50% on June 9, 2021, with the remainder in two equal annual installments beginning June 9. 2022. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 23:38 UTC |
KIRK THOMAS FDirector
|
GrantCommon Stock | 15,110 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-041295 · doc4.xml · nonDerivative · entry 1 KIRK THOMAS F · CIK 0001258258 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,235 F1 · shares: Represents grant of Restricted Stock Units (RSU's) under the Issuer's, 2018 Stock Option and Incentive Plan. These RSU's shall vest in four quarterly installments beginning September 9, 2020 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.